THE EVOLVING ROLE OF DISEASE-LEVEL PATIENT EXPERIENCE IN HEALTH TECHNOLOGY ASSESSMENT (HTA) AND REGULATORY DECISION-MAKING

被引：0
|
作者：
Hudzik, A. [1 ]
Sandman, K. [2 ]
Pham, S. [3 ]
机构：
[1] Univ N Carolina, Chapel Hill, NC 27515 USA
[2] AESARA, Acton, MA USA
[3] AESARA, Chapel Hill, NC USA
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCR6
引用
收藏
页码：S541 / S542
页数：2
相关论文
共 50 条
  • [1] Defining the role of the public in Health Technology Assessment (HTA) and HTA-informed decision-making processes
    Street, Jackie
    Stafinski, Tania
    Lopes, Edilene
    Menon, Devidas
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2020, 36 (02) : 87 - 95
  • [2] THE ROLE OF HEALTH RISK ASSESSMENT IN REGULATORY DECISION-MAKING
    SCROGGIN, DG
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1987, 194 : 26 - CHAL
  • [3] Interchangeability and substitution of biosimilars: is health technology assessment (HTA) a tool for decision-making?
    Ascef, Bruna de Oliveira
    Leonel da Silva, Renan Goncalves
    de Oliveira Junior, Haliton Alves
    De Soarez, Patricia Coelho
    [J]. CADERNOS DE SAUDE PUBLICA, 2019, 35 (09):
  • [4] SIMILARITIES AND DIFFERENCES IN HEALTH TECHNOLOGY ASSESSMENT (HTA) BODIES CONSIDERATIONS FOR DECISION-MAKING: USE OF PATIENT PREFERENCE STUDIES
    Morrison, S.
    Kumari, C.
    Castellano, G.
    Heinz, S.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S373 - S373
  • [5] EXPLORING THE ROLE OF PATIENT EXPERIENCE DATA AND PATIENT INVOLVEMENT IN HEALTH TECHNOLOGY ASSESSMENT DECISION MAKING
    Alonzo, C.
    Genel, T.
    Kostikas, M.
    Krol, M.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S346 - S346
  • [6] COMMON THREADS: REGULATORY AND HEALTH TECHNOLOGY ASSESSMENT (HTA) AGENCIESAVTM RECOMMENDATIONS ON REAL-WORLD EVIDENCE (RWE) USE IN DECISION-MAKING
    Jaksa, A.
    Gatto, N.
    Case, A.
    [J]. VALUE IN HEALTH, 2020, 23 : S315 - S316
  • [7] PATIENT VOICE AND PATIENT ENGAGEMENT IN VALUE ASSESSMENT FRAMEWORKS AND HTA DECISION-MAKING FOR GENE THERAPIES
    Dabbous, M.
    Raza, J.
    Connelly, B.
    Olid, Gonzalez A.
    Sullivan, N.
    [J]. VALUE IN HEALTH, 2024, 27 (06) : S312 - S312
  • [8] ANALYSIS OF FACTORS ASSOCIATED WITH REIMBURSEMENT DECISION MAKING IN HEALTH TECHNOLOGY ASSESSMENT (HTA)
    Bending, M. W.
    Kruger, J.
    Hutton, J.
    McGrath, C.
    [J]. VALUE IN HEALTH, 2009, 12 (03) : A11 - A11
  • [9] The role of Health Impact Assessment (HIA) in the decision-making
    Signorelli, Carlo
    Ricco, Matteo
    Odone, Anna
    [J]. EPIDEMIOLOGIA & PREVENZIONE, 2011, 35 (02): : 131 - 135
  • [10] ANALYSIS OF FACTORS ASSOCIATED WITH REIMBURSEMENT DECISION MAKING IN HEALTH TECHNOLOGY ASSESSMENT AGENCIES (HTA)
    Bending, M. W.
    Kruger, J.
    Hutton, J.
    McGrath, C.
    [J]. VALUE IN HEALTH, 2008, 11 (06) : A377 - A377
12345